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Measurements of relaxin and acute-phase proteins have not been validated for use
in canine serum as a method of pregnancy diagnosis. This means that handling and
anesthesia is still necessary to check the pregnancy status of most non-domestic canines.
Therefore, the intention of this study was to determine whether relaxin and/or acutephase proteins could be detected in the urine and/or feces of the domestic dog in order to
evaluate the potential for a noninvasive pregnancy test in canines. Blood, urine and feces
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CHAPTER I
INTRODUCTION
Diagnosing pregnancy and identifying pregnancy rates in non-domestic canines
can be difficult because traditional methods such as abdominal palpation and ultrasound
require multiple instances of handling and anesthesia that can be costly and inconvenient
as well as overly stressful for the animal (Monfort, 2003). For many non-domestic
species, the easiest method to detect and monitor pregnancy is by measuring progesterone
in fecal samples since elevated concentrations of progesterone are usually indicative of
pregnancy (Bauman et al., 2008; De Haas van Dorsser et al., 2006). However, this is not
feasible in canines because of an obligate pseudopregnancy that affects many nonpregnant females and involves an elevation in progesterone that closely mimics the
elevation seen during pregnancy (Bauman et al., 2008). Although pseudopregnancy is a
natural process in canines, it can complicate pregnancy diagnosis by causing nonpregnant females to take on the physical, behavioral, and hormonal appearance of
pregnancy (Gobello et al., 2001; Verstegen-Onclin and Verstegen, 2008). For this reason,
pregnancy in non-domestic canines is most often determined by measuring relaxin, the
only pregnancy-specific factor for canines. Relaxin has been used to diagnose pregnancy
in the domestic dog (Canis familiaris), gray wolf (Canis lupus), coyote (Canis latrans),
and many other canines (Bauman et al., 2008; Carlson and Gese, 2007; Verstegen-Onclin
and Verstegen, 2008). Additionally, a number of acute-phase proteins are also capable of
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determining pregnancy in the domestic dog (Hart, 1997; Ulutas et al., 2009; Vannucchi et
al., 2002).
Statement of the Problem
In canines, the assays for relaxin and acute-phase proteins necessary for
pregnancy diagnosis have only been validated for serum samples. Therefore, handling
and anesthesia are still necessary for blood collection in non-domestic species (Bauman
et al., 2008; Ulutas et al., 2009; Vannucchi et al., 2002). Chronic stress responses as a
result of "unpleasant" handling have been linked to a decrease in pregnancy rates in pigs
(Hemsworth et al., 1986). Blood collection is believed to cause stress in some
nondomestic carnivores, and both acute and chronic stress is known to adversely affect
reproduction in captive species (Goodrowe et al., 2000). This makes it difficult to
monitor pregnancy in non-domestic canines as it would be unwise to compromise
pregnancy by causing undue stress to the maternal body during handling and anesthesia.
Not only can handling and anesthesia be costly for researchers and stressful for the
animal, but an elevation in stress hormones of the animal may interfere with or mask
normal hormonal patterns (Monfort, 2003).
Furthermore, blood collection in wild populations is extremely difficult during the
period of gestation, and there are few samples available for wildlife biologists and
researchers during this time. For many non-domestic canines, there is very little
information on their reproductive physiology, including even basic parameters (Bauman
et al., 2004). This lack of information may be the result of the excessive handling that is
required to take serial serum samples for the study of reproductive hormones in canines.
In fact, what reproductive parameters that have been recorded for non-domestic canines
2

are the result of postmortem examinations of reproductive tissues taken during predator
control programs (Bauman et al., 2004; McNay et al., 2006). The best method to monitor
the reproductive status in non-domestic canines, both captive and wild, would be to
measure relaxin and/or acute-phase proteins via urine or feces. A urinary relaxin assay
has recently been developed for felines, and one study has shown that a urinary relaxin
assay is possible for identifying pregnancy in maned wolves (Chrysocyon brachyurus;
De Haas van Dorsser et al., 2006; Harris et al., 2008; Steinetz et al., 2009). Additionally,
urine concentrations of ceruloplasmin, an acute-phase protein, were used for pregnancy
diagnosis in the giant panda (Willis et al., 2011). However, to date, there have been no
studies to determine the presence of relaxin in the feces of pregnant canines, and the urine
and feces of canines have yet to be investigated for the presence of acute-phase proteins
capable of pregnancy diagnosis.
Objectives of the Study
The intent of this study was 1) to determine if relaxin and acute-phase proteins
could be detected in the urine and feces of the pregnant domestic bitch, 2) to compare
urine and fecal concentrations of relaxin and acute-phase protein with their respective
serum concentrations, and 3) to ultimately establish whether there was any potential for
developing a canine pregnancy test with either relaxin or acute-phase proteins in either
urine or feces. In light of the studies done by De Haas van Dorsser et al. (2006) on
urinary relaxin in felids, it was hypothesized that urinary relaxin would be capable of
diagnosing pregnancy in the domestic dog with elevations comparable to serum
concentrations. Likewise, since Willis et al. (2011) were able to use ceruloplasmin for
pregnancy diagnosis in the giant panda, it was also hypothesized that urine concentrations
3

of the acute-phase proteins fibrinogen, alpha-1 acid glycoprotein, and ceruloplasmin
would be capable of diagnosing pregnancy in the domestic dog as long as health could be
accounted for.
Significance of the Study
If urine and fecal concentrations of relaxin and acute-phase protein are
comparable to the concentrations found in serum, the results should validate the proposed
assays for use as a pregnancy test in the domestic bitch. These methods can then be used
as a basis from which to test the effectiveness of urinary and fecal measurements of
relaxin and acute-phase proteins in non-domestic canines. Being able to detect elevated
concentrations of relaxin or acute-phase proteins in urine or fecal samples of pregnant
bitches will allow for a noninvasive means of identifying and monitoring pregnancy that
would be highly advantageous for non-domestic canines. Due to overly zealous control
programs in addition to problems such as disease and habitat loss, several species of nondomestic canines have experienced declining populations that put them at risk for
extinction (Sillero-Zubiri et al., 2004). Many of these species depend on captive breeding
efforts to help restore their populations, and captive breeding often depends on being able
to identify and monitor pregnancy while causing the least amount of stress possible. In
some cases, such as the maned wolf, breeding success is low, and potential pregnancies
need to be monitored more strictly. Fortunately, a urinary relaxin assay has already been
shown to identify pregnancy in maned wolves, thus allowing for further insight into
maned wolf reproduction (Steinetz et al., 2009). It is, therefore, feasible that such
methods can be equally beneficial to other non-domestic canines.
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Furthermore, since progesterone can be measured in fecal samples, it would be
possible to noninvasively determine the reproductive status, whether pregnant or
pseudopregnant or anovulatory, of a canine if relaxin or acute-phase proteins could be
measured via urine or feces (Bauman et al., 2008). There have been very few studies
done on pseudopregnancy or anovulation in non-domestic canines, and the occurrence of
anovulatory cycles is unknown for most species. Being able to detect relaxin or acutephase proteins in the urine or feces of canines may open up many new research
opportunities into the reproductive processes of non-domestic canines since most
research occurs in zoo populations where urine and feces are often easily accessible.
Routine collection of urine and feces could allow for weekly or daily analysis of the
reproductive hormones of captive canines, furthering the development of species-specific
hormonal profiles for captive breeding purposes.
Lastly, most studies on the reproductive biology of non-domestic canines are
almost exclusively from captive populations due to the difficulty of obtaining serum
samples from wild populations. Obtaining multiple serum samples from an individual
canine in the wild is practically impossible. However, since collection of fecal samples is
a fairly routine practice in wildlife biology, studies into the reproductive biology of wild
populations could benefit significantly if relaxin or acute-phase proteins can be measured
in the feces. Reproductive factors, such as pregnancy rates and parturition rates, are
essential to understanding the population growth of wildlife species and, therefore, play
an important role in the balancing act of managing for non-domestic canines that are
detrimental to livestock species (McNay et al., 2006).
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Summary
In summary, pregnancy diagnosis in canines can be slightly more complicated due
to the obligate pseudopregnancy that is part of the canine reproductive cycle. While
progesterone is a sufficient means of pregnancy diagnosis for many other mammals, it is
not feasible in canines. To date, the hormone relaxin as well as certain acute-phase
proteins have been the only good indicators of pregnancy in the canine. Unfortunately, a
non-invasive method of detecting relaxin and the acute-phase proteins has not yet been
developed for the domestic dog or other non-domestic canines. Because breeding
programs and reproductive studies are often crucial for the management of many nondomestic species, this study has been designed to investigate the potential for less
invasive methods of detecting relaxin and acute-phase proteins in the domestic dog. The
intent is to determine whether or not relaxin and acute-phase proteins can be measured in
urine or feces and, if so, whether or not there is enough correlation with serum
concentrations to be used in pregnancy detection.
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CHAPTER II
THE CANINE REPRODUCTIVE PROCESS
The canine reproductive process, despite its distinctive characteristics, is a fairly
simple and straightforward form of reproduction. In fact, canine reproduction is thought
to resemble that of early placental mammals (Concannon et al., 2009). Like most other
mammals, canines have four stages in their reproductive cycle, each distinguished by
hormonal and physiological changes (Pineda, 2003). The luteal phase of their
reproductive cycle is the phase during which pregnancy and pseudopregnancy occur
(Pineda, 2003). The obligate pseudopregnancy experienced by non-pregnant females is
one of the more unique aspects of canine reproduction. Many of the same hormonal and
physiological changes that occur during canine pregnancy also occur during this obligate
pseudopregnancy, causing pregnant and non-pregnant females to exhibit similar physical
and behavioral signs (Gobello et al., 2001; Verstegen-Onclin and Verstegen, 2008).
Because of the similarities exhibited by pregnant and pseudopregnant canines,
developing accurate diagnostic methods for detection of pregnancy in canines has been
challenging, especially for non-domestic canines (Bauman et al., 2008). To date, relaxin
is the only pregnancy-associated factor found to reliably detect pregnancy in canines
although there has been some studies showing that certain acute-phase proteins can be
used in pregnancy diagnosis as well (Bauman et al., 2008; Hart, 1997; Vannucchi et al.,
2002). The following is an overview of the canine reproductive process comparing and
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contrasting pregnancy and pseudopregnancy and outlining current methods used in
canine pregnancy diagnosis.
Review of the Canine Estrous Cycle
In canines, there are four phases of the female reproductive cycle: proestrus,
estrus, diestrus, and anestrus (Pineda, 2003). These phases are differentiated by changes
in hormone concentrations and in vaginal epithelium, which coincide with characteristic
behavioral patterns (Kreeger, 2003; Packard, 2003; Pineda, 2003). Most canines are
monoestrous, having only one estrous cycle per year, and do not return to estrus even if
they fail to become pregnant (Asa and Valdespino, 1998; Kennelly and Johns, 1976). The
domestic bitch can sometimes cycle twice per year. However, this is usually considered a
result of a loss of seasonality instead of a true diestrous cycle (Pineda, 2003). In contrast,
non-domestic canines exhibit a seasonal breeding cycle, and some are considered highly
photoperiodic (Carlson and Gese, 2009; Mech, 1970).
Proestrus
Proestrus is characterized by rising concentrations of serum estrogen that, in
conjunction with vaginal bleeding, cause increased attractiveness and proceptive behavior
in bitches (Kreeger, 2003). This is due to the pheromones that are secreted in urine and
vaginal discharge. Onset of proestrus is considered to be the first day that blood is
discharged from the vulva. During this stage, follicular development occurs as a result of
gonadotropic stimulation. Follicular stimulating hormone (FSH) and luteinizing hormone
(LH) experience nearly parallel increases and then peak late in proestrus. Follicular
development causes increasing concentrations of estrogen, which peak during the last two
days of proestrus. In the Beagle bitch, estradiol-17β averaged 58 ± 7 pg/ml (Pineda,
8

2003). Similarly, estradiol-17β initially rises to 10-20 pg/ml in the gray wolf but then
later peaks in late proestrus at 30-50 pg/ml (Kreeger, 2003).
Proestrus averages 9 days in the domestic bitch with a range of 2−15 days, but it
generally lasts longer in non-domestic canines since most non-domestic canines
experience true monoestrum (Kreeger, 2003; Pineda, 2003). Captive wolves average a
proestrus length of 15.7 ± 1.6 days, but it can last much longer in the wild, potentially up
to 45 days (Kreeger, 2003). In the coyote, proestrus is well known for its extremely long
duration, lasting about 2−3 months on average (Amoss and Hodges, 1995).
Estrus
Estrus is considered the period of sexual receptivity and begins when the female
accepts the male for mating (Pineda, 2003). Acceptance of mating is characterized by a
lordosis-like stance and deflection of the tail to one side to allow mounting (Kreeger,
2003; Pineda, 2003). A copulatory lock-and-tie is then performed during mating (Pineda,
2003). Estrus is characterized by a decline in estrogen and a rise in progesterone that
causes this sexual behavior and leads up to the preovulatory LH surge (Kreeger, 2003).
Follicular luteinization and progesterone production occur as a result of increasing
concentrations of LH. Therefore, canines experience a unique preovulatory luteinization.
The preovulatory LH surge occurs on either the last two days of proestrus or the first two
days of estrus, and ovulation typically follows 48 hours after the preovulatory LH surge
(Pineda, 2003). Wolves demonstrate preovulatory LH surges of 5−15 ng/ml that can last
1−3 days. Two or three large tertiary follicles are generally present on the ovaries and are
lined by stratified layers of elongated granulosa cells that penetrate the antral space
(Sundeep and Adler, 2008).
9

In response to the LH surge, ovulation occurs, and estrogen-secreting ovarian
follicles further enlarge and luteinize, becoming the progesterone-secreting corpus luteum
(CL). In the gray wolf, estradiol-17β decreases abruptly to around 10−20 pg/ml after the
LH surge while progesterone increases rapidly above its baseline concentration of
1−3 ng/ml (Kreeger, 2003). Formation of the CL and initiation of progesterone
production, a process commonly referred to as metestrus, takes about 3-5 days in the
bitch (Pineda, 2003). In the coyote, ovulation can occur anywhere from the first day of
estrus until the ninth day of estrus, while it is thought to occur toward the end of estrus in
the gray wolf (Amoss and Hodges, 1995; Kreeger, 2003). Estrus is most easily
identifiable through vaginal cytology because the cells of the vaginal epithelium are
almost entirely keratinized superficial cells with few or no nuclei (Pineda, 2003). Estrus
lasts approximately 10 days in the domestic dog, gray wolf, and coyote (Amoss and
Hodges, 1995; Kreeger, 2003; Pineda, 2003).
Diestrus
The diestrus phase composes most of the luteal phase, during which the CL and
elevated concentrations of progesterone are at their most functional. Behaviorally, the
beginning of diestrus is considered to be when the bitch refuses to mate on two
consecutive days (Pineda, 2003). Since canines are spontaneous ovulators, both pregnant
and non-pregnant bitches develop CLs and enter the luteal phase unless non-pregnant
bitches are anovulatory (Kreeger, 2003; Pineda, 2003). Most bitches will develop at least
two large CLs in each ovary during early diestrus, but these CLs will regress into
cytoplasmic vacuoles in late diestrus (Sundeep and Adler, 2008). Due to the similarity in
hormonal concentrations and in length of diestrus between pregnant and non-pregnant
10

bitches, non-pregnant bitches in diestrus are often referred to as being physiologically
pseudopregnant (Asa and Valdespino, 1998). Diestrus ends with the return of
progesterone to its basal concentrations of 1 ng/ml and below (Pineda, 2003).
Generally, the diestrus phase is considered to last between 50-70 days, based upon
progesterone secretion, but it can vary depending upon the presence of pregnancy or the
intensity of a pseudopregnant reaction. Gestation in the bitch is consistently an average of
57 days; whereas, pseudopregnancy can last as long as 70−80 days (Pineda, 2003). In the
gray wolf, progesterone elevation generally lasts between 56−68 days, while gestation is
60−65 days (Kreeger, 2003). Gestation in the coyote is 60−63 days long (Carlson and
Gese, 2007).
Anestrus
Anestrus is the period of sexual quiescence following diestrus. Because of the
sexual inactivity during this stage, anestrus was thought to be a period of endocrine
inactivity as well, but recent studies have shown that many reproductive hormones rise
during late anestrus. Concentrations of FSH, in fact, are higher in the last month of
anestrus than they are during proestrus. In response, estradiol-17β increases to as high as
46 pg/ml during late anestrus (Pineda, 2003). This causes early follicular development to
occur, with several primary and secondary follicles seen in the ovaries in late anestrus
(Sundeep and Adler, 2008). The reason why there are no reproductive behaviors that
correlate with the ovarian activity during anestrus is not yet understood although it is
suspected that the expression of estrous behaviors is inhibited by low concentrations of
progesterone during anestrus. Furthermore, lactation occurs at the beginning of anestrus
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in postpartum bitches and lasts for 6−9 weeks, during which concentrations of prolactin
are increased (Pineda, 2003).
In the domestic bitch, anestrus can range anywhere from 40−270 days. Because
the domestic bitch is aseasonal, anestrus is extremely variable, not only between breeds
but also between individuals within the same breed and between cycles within the same
individual (Pineda, 2003). In wild canines, the period of anestrus is more consistent,
varying slightly depending upon region. For example, June to December is considered to
be the period of anestrus in the gray wolf (Kreeger, 2003).
Anovulatory Cycles
When bitches fail to reach the threshold value of 2 ng/ml during the period of
cytological estrus and therefore fail to enter into diestrus, they instead become anestrous.
This abnormality in the canine estrous cycle is referred to as anovulation. Anovulation
may be caused by an insufficient secretion of hormones to stimulate normal ovulation or
the failure of the ovary to respond to stimulation. For example, the ovary may not
produce a strong enough estrogen signal to initiate the LH surge, or the ovary may simply
not respond to a normal LH surge. Anovulatory cycles are uncommon in the domestic
dog, one study reporting an occurrence as little as 1.2% among bitches in a breeding
management program (Meyers-Wallen, 2007). However, anovulation has been known to
persist for over two years in some adult captive wolves (Kreeger, 2003).
Review of the Canine Luteal Phase: Pregnancy versus Pseudopregnancy
One of the major challenges in canine reproduction has been to distinguish the
differences between pregnancy and pseudopregnancy. Physiological pseudopregnancy
refers to a naturally extended luteal phase that closely mimics the physical, behavioral,
12

and hormonal characteristics of pregnancy (Gobello et al., 2001; Verstegen-Onclin and
Verstegen, 2008). In canines, bitches that do not become pregnant after ovulation enter
this extended luteal phase (Pineda, 2003). It is thought that psuedopregnancy originally
evolved in social canines as a function of cooperative breeding since it offered
advantages in rearing young and maintaining social cohesion (Creel et al., 1991;
Concannon et al., 2009). However, in veterinary medicine, clinical pseudopregnancy is
considered an endocrine disorder of the domestic dog due to the problematic behaviors
associated with pseudopregnancy (Gobello et al., 2001). Despite the similarities between
pregnancy and pseudopregnancy, there are a number of endocrine and physiological
differences to distinguish one from the other (Concannon et al., 2009; Bauman et al.,
2008; Verstegen-Onclin and Verstegen, 2008; Vannucchi et al., 2002).
Endocrine Characteristics
Progesterone
Both pregnancy and pseudopregnancy are characterized by an elevation of plasma
progesterone beyond its threshold value of 1−2 ng/ml that peaks around 20−30 days after
the LH surge (Concannon et al., 2009; Verstegen-Onclin and Verstegen, 2008). Peak
concentrations of plasma progesterone are similar between pregnant and pseudopregnant
bitches (Concannon et al., 2009; Concannon et al., 1975). This elevation in progesterone
causes the mammary development and the development and enlargement of the uterus
that is seen in pregnancy and often in pseudopregnancy (Gobello et al., 2001; Pineda,
2003).
Pregnancy-associated progesterone is actually produced by the CL at significantly
higher concentrations than progesterone in pseudopregnant bitches, but these higher
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concentrations dwindle rapidly as they are metabolized in the periphery and consumed by
the placenta. This results in a 25% or more decrease in circulating progesterone
concentration (Concannon et al., 2009). For this reason, concentrations of plasma
progesterone appear similar between pregnant and pseudopregnant bitches. The
difference in concentrations of progesterone can only be seen when progesterone
metabolites are measured from the feces and compared with plasma progesterone
(Concannon et al., 2009; Verstegen-Onclin and Verstegen, 2008).
After its peak, progesterone begins to decline in both pregnant and
pseudopregnant bitches around 30 days after the LH surge (Verstegen-Onclin and
Verstegen, 2008). In pregnant bitches, this decline culminates in parturition, during
which progesterone drops rapidly and becomes undetectable within a day (Pineda, 2003).
In pseudopregnant bitches, progesterone declines more slowly, possibly as a result of
gradual luteal regression (Concannon et al., 2009; Pineda, 2003). This is true for wolves
as well, as one pseudopregnant wolf was documented with a luteal phase of 70 days
based on elevated concentrations of progesterone (Seal et al., 1979). Overall,
progesterone elevation is shorter in duration and more abrupt in its decline during
pregnancy than during pseudopregnancy (Verstegen-Onclin and Verstegen, 2008).
Estrogen
Some studies have shown that estrogen undergoes a pregnancy-specific rise in
luteal secretion in the domestic bitch (Concannon et al., 2009; Concannon et al., 1975).
Although estrogens decrease at the end of estrus, estradiol-17β experiences a significant
increase about 10−15 days after the LH surge and remains elevated during pregnancy
until Day 64. It is suggested that this rise in estradiol is related to estradiol’s ability to
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sustain luteal function and to stimulate progesterone secretion (Verstegen-Onclin and
Verstegen, 2008). However, there is no prepartum rise in estradiol-17β in the gray wolf.
Instead, concentrations of estradiol remain between 10−30 pg/ml throughout diestrus
(Seal et al., 1979). Furthermore, other studies of the domestic bitch have found no
significant difference in concentrations of estrogen between pregnant and pseudopregnant
bitches (Verstegen-Onclin and Verstegen, 2008).
Prolactin
After Day 30, prolactin is the main luteotrophic factor necessary for supporting
the CL in both pregnant and pseudopregnant bitches (Gobello et al., 2001; VerstegenOnclin and Verstegen, 2008). Prolactin forms a complex with LH, whose function in
diestrus is still under speculation (Pineda, 2003; Verstegen-Onclin and Verstegen, 2008).
Additionally, prolactin has also been known to play a role in the development and
differentiation of mammary tissue (Kooistra and Okkens, 2002). Prolactin rises slightly
above basal concentrations in mid-gestation and remains elevated throughout gestation
and lactation (Verstegen-Onclin and Verstegen, 2008). In the pseudopregnant bitch,
concentrations of prolactin are slightly lower, but not significantly low enough to
distinguish pregnancy from pseudopregnancy (Concannon et al., 2009). Furthermore,
there is much individual variation in prolactin concentration in the domestic bitch
(Verstegen-Onclin and Verstegen, 2008).
Prolactin is likely the hormone responsible for the maternal behavior exhibited
during pregnancy and pseudopregnancy, as it has been linked to parental behavior in
many other species (Asa and Valdespino, 1998). In the domestic bitch, the unwanted
nesting behaviors of pseudopregnant bitches are often treated with dopamine agonists,
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such as bromocriptine, to inhibit prolactin secretion, further supporting the link between
increased prolactin secretion and maternal behaviors (Pineda, 2003; Verstegen-Onclin
and Verstegen, 2008). All wolves, regardless of gender and reproductive status, exhibit a
circannual rhythm of prolactin, with peaks just prior to summer solstice, suggesting that
prolactin may be involved in the reestablishment of gonadotropin secretion and may
essentially serve as a cue for breeding activity (Kreeger et al., 1991). Furthermore,
elevations of prolactin in wolves during spring may cause the priming of parental
behavior, such as den construction and pup feeding, which has been observed in both
pregnant and pseudopregnant pack members (Kreeger et al., 1991; Mech et al., 1996;
Packard, 2003).
Relaxin
Although relaxin can be produced by both the ovary and the placenta of the bitch,
it is secreted primarily by the trophoblasts of the placenta (Klonisch and HombachKlonisch, 2000; Klonisch et al., 1999). In carnivores like the dog and cat, placentation is
endotheliochorial and zonary, and trophoblasts actively pervade the uterine endometrium
into the basal lamina (Klonisch and Hombach-Klonisch, 2000). During pregnancy,
concentrations of relaxin rise to 8−10 μg/ml in the domestic bitch, which has one of the
highest reported concentrations of serum relaxin for any species (Steinetz et al., 1996).
Relaxin is detectable within serum around Day 18 of gestation and peaks around Day 35
in the bitch (Klonisch et al., 1999; Steinetz et al., 1996). In contrast, serum relaxin is
undetectable in bitches that are pseudopregnant, anovulatory, or hysterectomized, making
relaxin a pregnancy-specific hormone for canines (Klonisch et al., 1999).
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In placental mammals, relaxin is probably most well known for its effects on the
cervix and vagina that allow for the passage of young. However, relaxin has a myriad of
functions during pregnancy that differ depending upon species (Sherwood, 2004; Steinetz
et al., 1989; Swabe and Büllesbach, 1994). Relaxin is thought to act through autocrine or
paracrine mechanisms to prepare the uterine endometrium for implantation since it is
involved in uterine growth and development as well as myometrial contractility
(Sherwood, 2004). Although the hormone’s specific function in the placenta has yet to be
determined, it is suspected that relaxin is a placental growth factor, as it is associated with
highly proliferative fetal tissues in the domestic bitch. For this reason, relaxin may also
be used to identify the onset of parturition or to predict unexpected abortion, as it
decreases to undetectable concentrations during both incidents (Klonisch and HombachKlonisch, 2000; Klonisch et al., 1999). Similarly, it has been linked to an increase in fetal
weights in rats (Sherwood, 2004). Though it has yet to be fully proven, it has been
suggested that relaxin plays a role in follicular growth in the pig (Sherwood, 2004).
Parturition and Luteal Regression
When the fetal pituitary-adrenal axis matures at the end of pregnancy,
concentrations of fetal glucocorticoids rise, causing increased prostaglandin production.
In response to elevated prostaglandins, the CL undergoes luteolysis, and progesterone
sharply declines to concentrations less than 2 ng/ml. Generally, parturition occurs a few
days after this sharp decline in progesterone (Verstegen-Onclin and Verstegen, 2008).
In contrast, luteal regression in the non-pregnant bitch is a slow process. Without
fetuses to initiate prostaglandin production, endogenous prostaglandin is not involved in
luteal regression, as there is no evidence of expression of PGF synthetase on the CL
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(Concannon et al., 2009; Verstegen-Onclin and Verstegen, 2008). Furthermore, the uterus
of the non-pregnant bitch does not appear to be a factor in luteolysis (Pineda, 2003).
Because the bitch’s reproductive system seems to be lacking in luteolytic factors, it is
likely that luteal regression is simply a result of the aging of the CL and that luteal cells
are preprogrammed to endure for two months to ensure potential pregnancy is successful
(Concannon et al., 2009; Pineda, 2003). Therefore, concentrations of plasma
progesterone, while decreasing markedly at parturition in the pregnant bitch, may persist
longer than two months in the non-pregnant bitch (Pineda, 2003).
Lactation
Milk secretion occurs when progesterone, which suppresses lactation, declines at
parturition (Verstegen-Onclin and Verstegen, 2008). However, since progesterone also
declines during luteal regression in pseudopregnant bitches, milk secretion is commonly
seen among pseudopregnant bitches, and it has been documented in some wolves (Asa
and Valdespino, 1998; Gobello et al., 2001). There has been much speculation as to the
role of lactation in pseudopregnant canines since pseudopregnant dwarf mongooses have
been known to use spontaneous lactation for communal nursing (Concannon et al., 2009;
Creel et al., 1991; Packard, 2003). However, most researchers seem to believe that milk
secretion from pseudopregnant wolves does not offer any function in communal nursing.
All cases of cooperative nursing in wolves have only been observed among postpartum
bitches (Packard, 2003).
Review of Pregnancy Diagnosis in Canines
While pregnancy diagnosis in most mammals can be performed by monitoring
fecal or serum progesterone values, this is not possible with canines because both
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pregnant and pseudopregnant females have elevated progesterone values (Bauman et al.,
2008). Although it is fairly routine to perform pregnancy tests in domestic bitches,
pregnancy diagnos can be more difficult in non-domestic canines, who are subject to
greater stress during handling. In the past, pregnancy rates in wolves and other nondomestic canines were mainly calculated from post mortem examinations. Ultrasound has
also been used in wolves as a reliable means of pregnancy diagnosis, although it requires
anesthesia (McNay et al., 2006). However, the relaxin assay is by far the most common
method of diagnosing pregnancy in both domestic and non-domestic canines due to its
accuracy and reliability (Bauman et al., 2008). Additionally, some acute-phase proteins
have gained increasing recognition for their ability to indicate early pregnancy in the
domestic bitch (Hart, 1997; Vannucchi et al., 2002).
Relaxin
The relaxin molecule is a 6-kDa polypeptide that is structurally similar to insulin
(Steinetz et al., 1996; Steinetz et al., 1989). The diverse functions of relaxin across
species can be attributed to the variability of its structure between species and even
between breeds, its sequences differing an average of 50% between relaxin molecules of
different species (Stewart et al., 1992; Schwabe and Büllesbach, 1994). However, the
receptor-binding region on relaxin is specifically located at the mid-region of the B chain
helix in most species. For that reason, there is a high degree of biological cross-reactivity
among different species (Schwabe and Büllesbach, 1994).
Relaxin has been found in ovarian tissues, seminal fluid, prostatic tissues, and
various connective tissues of many species (Gelsleichter et al., 2003; Niebauer et al.,
2005; Ryan et al., 1997; Sherwood, 2004; Steinetz et al., 1989; Weiss, 1989). During
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pregnancy, the main source of relaxin production is the ovary for the sow, cow, and rat
and the placenta for the bitch, queen, mare, and rabbit (Anderson et al., 1973; Anderson
and Long, 1978; Addiego et al., 1987; Fields and Larkin, 1980; Fields et al., 1980;
Tsutsui and Stewart, 1991; Stewart et al., 1982). Because it is produced primarily by the
placenta in canines, relaxin has long been considered the only hormonal marker of
pregnancy in canines (Bauman et al., 2008; Carlson and Gese, 2007; Verstegen-Onclin
and Verstegen, 2008). It has been used to diagnose pregnancy in the coyote, gray wolf,
Mexican gray wolf (Canis lupus baileyi), fennec fox (Vulpes zerda), and island fox
(Urocyon littoralis; Bauman et al., 2008; Carlson and Gese, 2007; De Haas van Dorsser
et al., 2007; DiGangi et al., 2010).
Urinary Relaxin Assays
Due to its small size and molecular weight, it has been suggested that the relaxin
might pass through the glomeruli of the kidney and be excreted relatively unaltered in the
urine (De Haas van Dorsser et al., 2006). The potential of measuring relaxin in urine for
wildlife conservation was first reported by Steinetz et al. (2005) in a study on the giant
panda (Ailuropoda melanoleuca) in which relaxin was measured in paired serum and
urine samples. Although urinary relaxin appeared to be pregnancy-specific, it was
determined to be unreliable for pregnancy diagnosis in the giant panda due to sporadic
fluctuations in urinary relaxin combined with complicating physiological factors.
However, the significance of this study was that it demonstrated the ability to detect
relaxin in urine as a possible means of non-invasive pregnancy diagnosis in other species
(Steinetz et al., 2005).
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Subsequently, De Haas van Dorsser et al. (2006) validated the use of a urinary
relaxin radioimmunoassay for pregnancy diagnosis in felines. Paired serum and urine
samples were taken from pregnant and non-pregnant domestic cats and leopards
(Panthera pardus) and tested for concentrations of relaxin using the double-antibody
canine relaxin radioimmunoassay (RIA). Urinary relaxin became detectable in the
pregnant cat around 21−28 Days and in the pregnant leopard around 25−28 Days. For
both species, the concentrations of urinary relaxin compared favorably to those seen in
serum, allowing pregnancy diagnosis via urine as early as the third or fourth week of
gestation (De Haas van Dorsser et al., 2006). Further studies on urinary relaxin showed
that it could indicate late gestation pregnancy in the Iberian lynx (Lynx pardinus) and was
likely capable of indicating pregnancy in the Pallas cat (Otocolobus manul) and the
maned wolf (Braun et al., 2009; Harris et al, 2008; Steinetz et al., 2009).
Acute-Phase Proteins
Recent studies on acute-phase proteins have unveiled their potential in pregnancy
diagnosis of the domestic bitch, even in the development of an early pregnancy test
(Ulutas et al., 2009; Vannucchi et al., 2002). Acute-phase proteins are proteins produced
by the liver during acute-phase response to inflammation or infection (Evans and
Anderton, 1992). They are known to be involved in the immune response and the
recovery of damaged tissue, but they can also be released under normal physiological
conditions, such as pregnancy (Evans and Anderton, 1992; Ulutas et al., 2009). In cyclic,
non-pregnant bitches, concentrations of acute-phase proteins remain stable, resulting in
significant differences in concentrations of acute-phase protein between pregnant and
pseudopregnant bitches. Furthermore, acute-phase proteins do not seem to be affected by
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variations in sexual hormones or by external stimuli, such as excitement or stress (Ulutas
et al., 2009). The rise in acute-phase proteins during pregnancy is, therefore, attributed to
an inflammatory reaction of the maternal body to embryonic implantation, occurring
around 16−18 days after the LH surge, and subsequent placental growth (Ulutas et al.,
2009; Vannucchi et al., 2002). This inflammatory response stimulates acute inflammatory
response mediators to produce acute-phase proteins (Vannucchi et al., 2002). In the
domestic dog, seven acute-phase proteins have been evaluated for their usefulness in
pregnancy diagnosis: fibrinogen, ceruloplasmin, haptoglobin, C reactive protein,
seromucoid, alpha-1 acid glycoprotein, and α2 globulin. Of these, fibrinogen,
ceruloplasmin, and alpha-1 acid glycoprotein appear to have the most consistently
reliable results (Ulutas et al., 2009; Vannucchi et al., 2002).
Although acute-phase protein panels have been identified in the domestic dog as
having 97% accuracy rate in pregnancy diagnosis, it is important to realize that acutephase proteins are not pregnancy-specific factors (Evans and Anderton, 1992). Pregnancy
diagnosis by acute-phase protein panels is only effective in healthy animals since acutephase proteins will respond to inflammation and infection. Unhealthy, infected animals
may cause false-positives (Ulutas et al., 2009; Vannucchi et al., 2002).
Fibrinogen
Fibrinogen has been recognized in numerous studies as a method for diagnosing
pregnancy in the domestic bitch. Fibrinogen peaks in mid-gestation, usually around Day
28 (Concannon et al., 1995; Concannon et al., 1996; Hart, 1997; Ulutas et al., 2009;
Vannucchi et al., 2002). However, Ulutas et al. reported that there was a significant rise
in fibrinogen during the first half of pregnancy as well (2009). Most studies show that
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fibrinogen is significantly elevated throughout pregnancy until parturition (Ulutas et al.,
2009; Vannucchi et al., 2002). However, Concannon et al. reported that fibrinogen
peaked between Days 25−50, declining before parturition (1995). The variation seen
among these studies may be due to the different assays that were used to measure
fibrinogen (Concannon et al., 1995; Concannon et al., 1996; Ulutas et al., 2009;
Vannucchi et al., 2002). Bitches are classified as pregnant with 100% accuracy if
concentrations of fibrinogen are over 280 mg/dl, and they are classified as non-pregnant
if concentrations of fibrinogen are below 230 mg/dl (Root Kustritz, 2005; Vannucchi et
al., 2002).
Ceruloplasmin
Ceruloplasmin is an α2-glycoprotein that protects host tissues during
inflammatory processes, transports copper, and functions in antioxidant defense (Cerόn
and Martínez-Subiela, 2004). Its role in the metabolism and transportation of copper
makes ceruloplasmin important to parturition, prostaglandin biosynthesis, and
gonadotropin synthesis and release (Ulutas et al., 2009). Ceruloplasmin is known to
increase by 140% in response to an induced inflammatory process (Vannucchi et al.,
2002). In gestation, concentrations of ceruloplasmin increase by 100% during the second
week and have been shown in some studies to increase during the first week as well
(Ulutas et al., 2009; Vannucchi et al., 2002). These concentrations remain significantly
elevated throughout gestation, and increasing estradiol-17β towards the end of gestation
causes a second increase in concentrations of ceruloplasmin (Ulutas et al., 2009;
Vannucchi et al., 2002). Values above 7.47 U/l between Days 21−42 of gestation can be
significant for diagnosing pregnancy (Vannucchi et al., 2002). Furthermore,
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ceruloplasmin was examined in the urine of the giant panda as a potential marker of
pregnancy. Urinary ceruloplasmin was found to be elevated in pregnant pandas from the
first week of pregnancy until 20−24 days before parturition but was not found to increase
in pseudopregnant pandas (Willis et al., 2011).
Alpha-1 Acid Glycoprotein
Glycoproteins, also known as inflammatory proteins, offer an overall profile of an
inflammatory reaction. Essentially, they represent the sum of the inflammatory reactions
seen from the acute-phase proteins. Alpha-1 acid glycoprotein specifically is considered a
fetal protein for most species since it is not usually found in large concentrations in the
serum of adult animals (Gruys et al., 2005). Vannucchi et al. found that concentrations of
alpha-1 acid glycoprotein (AGP) increased significantly around Day 21 of gestation in
pregnant bitches and peaked during the 6th week of gestation (2002).
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CHAPTER III
MATERIALS AND METHODS
Animals
Domestic dogs used in this study were from local animal shelters in northern
Mississippi and enrolled in the Spay-and-Neuter Program offered by the Mississippi State
University College of Veterinary Medicine (Mississippi State, MS, USA). They were
temporarily housed aboard the College of Veterinary Medicine's mobile veterinary unit
for routine castration or ovariohysterectomy. Animals were deprived of food and water
about 12 hours before surgery. Dogs were of various breeds, ages, and weights. Dogs
were divided into four weight classes: < 9 kg, 9−18 kg, 18−32 kg, and > 32 kg.
Specimen Collection
Blood, urine, and feces were collected once from 13 pregnant bitches, 3 nonpregnant bitches, and 2 male dogs presented for routine castration or ovariohysterectomy.
Bitches were assessed by a veterinarian for pregnancy based on observation and palpation
of the uterus. All animals were routinely anesthetized intramuscularly or intravenously
with 35 mcg/kg of Dexmedetomidine, 0.35 mg/kg of Butorphanol, and 3.5 mg/kg of
Ketamine before surgery. Additionally, 4.4 mg/kg of Carprofen was administered
subcutaneously after blood collection. A saphenous venipuncture with a 20- or 22-gauge
needle was performed to collect 7 ml of blood in red top and purple top blood separator
tubes. Urine was collected by free catch or manual expression of the bladder, and feces
was collected by free catch or sanitized fecal loop. Following ovariohysterectomy,
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ovaries and uteri of all 16 bitches were saved for additional analysis. Blood was
centrifuged into serum, which was stored at -20˚C. Feces were stored at -20˚C, and urine
was stored at -80˚C. Reproductive tissues were fixed in neutral buffered 10% formalin.
Individual serum and urine samples were dispensed by pipette into four sets of
microcentrifuge tubes for use with each assay to prevent freeze-thaw cycles. Since the
fibrinogen assay had to be run twice on serum and fecal samples and the AGP assay had
to be run twice on fecal samples, some thawing and refreezing did occur with these sets
of samples.
Pregnancy and Health Assessment
Pregnancy was confirmed by evaluating uteri for the presence of embryos or
fetuses. Ovaries and uteri of the non-pregnant bitches were assessed histologically for
signs of pregnancy. Crown-rump length, head diameter, and body diameter of each fetus
was measured to the nearest millimeter. Body diameter was measured as an average of
two measurements, one caudal to the shoulders and one cranial to the hips. Based on
these measurements, average fetal measurements for each litter were calculated.
Gestational age (GA), defined as number of days from the LH surge, was calculated from
litter measurements according to the equation and chart developed by Yeager et al.
(1992) for estimation of gestational age in Beagle fetuses during ultrasound. Since
Kutzler et al. (2003) found that small and giant breeds deviate from normal fetal growth
trend, the suggested correction factors were used for dogs weighing outside of 9−32 kg.
Each litter was classified according to gestational age: early post-implantation gestation
(Day 20-30), mid-gestation (Day 30-50), and late gestation (over Day 50).
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Because acute-phase proteins also become elevated due to inflammation and
infection, it was necessary to assess the health status of animals used in this study (Evans
and Anderton, 1992). At sample collection, a brief health assessment was performed by
the veterinarian, and any observable health problems were recorded on a health
assessment form. All animals were visually evaluated by the veterinarian for mange, flea
and tick problems, fever, wounds, inflammation, abnormally high stress response, and
other observable issues. Complete blood counts (CBC) were performed by the clinical
pathology laboratory at Mississippi State University College of Veterinary Medicine, and
results were assessed by a clinical pathologist to screen for disease. For simplicity's sake
in assessing health against pregnancy for the acute-phase proteins, each individual animal
was assigned a health grade from 0−4 based on the number of abnormalities within their
white blood cell counts. Grade 0 was indicative of white blood cell counts within normal
limits; grade 1 was indicative of one abnormality within white blood cells counts; grade 2
was indicative of two abnormalities within white blood cell counts, etc.
Laboratory Assays
Relaxin
Relaxin was measured by means of the double-antibody canine relaxin
radioimmunoassay (RIA; Steinetz et al., 1996). This method involves synthetic canine
relaxin for the standards and iodination of synthetic canine relaxin with 125I as the label.
Anti-canine relaxin is used as the primary antibody, and goat anti-rabbit IgG is used as
the secondary antibody. Radioactivity was measured through a gamma counter. Samples
were run in triplicate in the Endocrinology Laboratory at the Nelson Institute of
Environmental Medicine, NYU School of Medicine (Tuxedo, NY, USA).
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Fecal Extraction
Extraction of relaxin from feces was modeled following the procedure by
Schwabe et al. (1978) for extraction of relaxin from the hyena placenta. Feces were
allowed to partially thaw and then weighed on a gram scale. For every 1 g of feces, 10 ml
of H2O and 1 ml of ice cold concentrated HCl was added and mixed thoroughly with the
feces. The mixture was placed on a magnetic stirrer at 4˚C for approximately 4 hours.
Then 84 ml of acetone was added to the mixture, placed on the magnetic stirrer, and
stored overnight at 4˚C. The following day, the mixture was centrifuged at 1000xg for 30
minutes to create a precipitate. The clear supernatant was removed and added to 5
volume acetone that had been pre-cooled to -15˚C. The supernatant-acetone solution was
placed on a magnetic stirrer and stored overnight again at 4˚C. The following day,
precipitate was collected through centrifugation and was decanted and dried using
nitrogen gas. This precipitate was used in the relaxin RIA (Schwabe et al., 1978).
Acute-Phase Proteins
Fibrinogen, alpha-1 acid glycoprotein, and ceruloplasmin were measured in
serum, urine, and feces. Fibrinogen was measured using a quantitative two-site enzyme
linked immunoassay (ELISA) from MyBioSource (San Diego, CA, USA) following the
manufacturer's instructions. In this assay, fibrinogen from the samples forms complexes
with the anti-fibrinogen antibodies that have been adsorbed to the surface of polystyrene
microtitre wells. Anti-fibrinogen antibodies conjugated with horseradish peroxidase are
then added to form complexes with previously bound fibrinogen. Finally, a chromogenic
substrate is added to assay the enzyme bound to the immunosorbent. Optical densities
were calculated using an ultraviolet-visible spectrophotometer, and concentrations were
automatically calculated from the optical density by the SoftMax Pro software.
28

Alpha-1 acid glycoprotein was also measured using a quantitative two-site
enzyme linked immunoassay from MyBioSource (San Diego, CA, USA) following the
manufacturer's instructions. As with the fibrinogen ELISA, AGP from the samples forms
complexes with the anti-AGP antibodies that have been adsorbed to the polystyrene
microtitre wells. Anti-AGP antibodies conjugated with horseradish peroxidase are then
added to form complexes with previously bound AGP. Finally, a chromogenic substrate
is added to assay the enzyme bound to the immunosorbent. Optical densities were
calculated using an ultraviolet-visible spectrophotometer, and concentrations were
automatically calculated from the optical density by the SoftMax Pro software.
A trial set of serum, urine, and fecal extracts from four dogs (3 pregnant females,
1 male) was sent to the Memphis Zoo (Memphis, TN) for ceruloplasmin testing.
Ceruloplasmin was measured through the oxidasic activity method proposed by
Sunderman and Nomoto (1970) for human serum and modified by Willis et al. (2011) for
use in urine in the giant panda. This assay determines the concentration of ceruloplasmin
based on the rate of formation of a colored product from ceruloplasmin and the substrate
N,N-dimethyl-p-phenylenediamine. Ceruloplasmin concentration was proportional to the
rate of colorimetric change in each sample (Willis et al., 2011).
Fecal Extraction
Acute-phase proteins were extracted from feces using a wash buffer (Fischer
Scientific) according to the fecal extraction process used in the Human Alpha-1Antitrypsin ELISA from BioVendor (Candler, NC, USA). A mixture of 100 mg of feces
and 5 ml of wash buffer was created and homogenized using a vortex mixer. Then 1 ml
of the mixture was added to a polystyrene centrifuge tube and centrifuged for 10 minutes
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at 10000xg. The resulting supernatant was then diluted using wash buffer according to
the dilution protocol for each assay.
Urinary Creatinine
Creatinine assays were performed for each urine sample in the diagnostic
laboratory at the Mississippi State University College of Veterinary Medicine
(Mississippi State, MS) in order to express concentrations of relaxin and acute-phase
protein relative to creatinine. Creatinine was measured using a quantitative absorbance
assay from Alfa Wassermann Diagnostic Technologies, LLC (West Caldwell, NJ). In an
alkaline medium, creatinine and picric acid react to create a red-orange colored complex
that strongly absorbs at 505 nm. The rate of absorbance over a fixed time interval is
directly proportional to creatinine concentration. Urine protein to creatinine ratios were
then calculated for each set of urine data to standardize urine values.
Data Analysis
Data was evaluated by histograms and Q-Q plots for distribution and the
possibility of outliers. The data did not appear to be normally distributed. Therefore,
Spearmans rank correlation was used to determine statistical dependence between serum
and urine and between serum and feces for each assay. Spearmans rank correlation was
also used to determine statistical dependence of concentrations of relaxin, fibrinogen, and
AGP with gestational age in pregnant bitches. Spearmans rank correlation is a
nonparametric measurement of statistical dependence and was performed using the
CORR procedure from SAS for Windows. A probability of P < 0.05 was used to indicate
significance of the correlation coefficient for each set of data.
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The independent t-test was used to determine whether there was a statistical
difference between mean concentrations of relaxin, fibrinogen, and AGP in pregnant
bitches and mean concentrations of relaxin, fibrinogen, and AGP in non-pregnant bitches.
The Satterthwaite method was used with serum and urinary relaxin, urinary AGP, and
urinary fibrinogen since their variances were found to be unequal. The pooled method
was used for serum and fecal AGP and serum and fecal fibrinogen since their variances
were found to be equal. A probability of P < 0.05 for the two-sided P value was used to
indicate a significant difference in mean concentrations between pregnant bitches and
non-pregnant bitches with the expectation that pregnant bitches should have higher mean
concentrations. Mean concentrations were expressed as x ± SD. An alpha level of 0.05
was used for all statistical tests.
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CHAPTER IV
RESULTS
Blood, urine, and feces were collected from 13 pregnant bitches, 3 non-pregnant
bitches, and 2 male dogs. All 13 bitches assessed as pregnant by the veterinarian were
carrying fetuses. In contrast, no fetuses were present in the uteri of the three bitches
assessed by the veterinarian as non-pregnant. Based upon histological observations of the
ovaries and uteri, two non-pregnant bitches (Dogs 04 and 06) were physiologically
pseudopregnant due to the presence of corpora lutea. The third non-pregnant bitch (Dog
03) had very little activity within her ovaries and uterus and was determined to be
anovulatory. In pregnant bitches, number of fetuses per litter ranged from 1−12 and
averaged 6 fetuses per little. Gestational age of each litter, as calculated from fetal
measurements, ranged from 26−57 days and averaged 43 days (see Table 1). Most
pregnant bitches were in mid-gestation between Days 30−50, with two bitches classified
as early gestation and three classified as late gestation (see Table 2). The gestational age
of each litter was consistent with the physical development of the fetuses according to the
chart adapted from Pineda (2003) and Pretzer (2008; see Appendix A).
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Table 1

Gender, weight, breed, litter size, and gestational age for eighteen omestic
dogs sampled from February to July 2011 in northern Mississippi

Animal ID

Gender

Weight

Breed

Litter Size

GA (days)

Dog 03
F
9−18 kg Cocker Spaniel
–
–
Dog 04
F
< 9 kg
Beagle
–
–
Dog 05
F
< 9 kg
Beagle
–
–
Dog 06
M
9−18 kg
Rat Terrier
–
–
Dog 07
F
< 9 kg
Chihuahua
5
34 ± 3
Dog 08
F
18−32 kg
Hound Mix
11
43 ± 3
Dog 09
F
18−32 kg
Mix
12
26 ± 3
Dog 10
F
18−32 kg
Lab Mix
6
57 ± 3
Dog 11
F
18−32 kg
Pointer Mix
10
48 ± 3
Dog 12
F
9−18 kg
Terrier Mix
5
45 ± 3
Dog 13
F
18−32 kg
Mix
8
29 ± 3
Dog 14
F
9−18 kg
Husky Mix
7
38 ± 3
Dog 15
F
< 9 kg
Rat Terrier
5
58 ± 3
Dog 16
F
9−18 kg
Mix
1
44 ± 3
Dog 17
F
< 9 kg
Rat Terrier
3
38 ± 3
Dog 19
F
9−18 kg
Mix
6
52 ± 3
Dog 20
M
9−18 kg
Pit Bull Mix
–
–
Dog 21
F
9−18 kg
Mix
3
40 ± 3
NOTE: GA = gestational age, defined as days from the surge of luteinizing hormone
Of the 18 domestic dogs samples, 3 were indicated by the veterinarian as having
observable health problems: one with wounds/inflammatory sites and flea infestation
(Dog 09), one with tick infestation (Dog 10), and one with flea infestation (Dog 11).
According to CBC results, 9 animals presented for possible inflammation and infection
due to elevated white blood cell counts. The remaining 9 animals did not appear to be
experiencing significant inflammation or infection based upon their white blood counts.
Dog 07 presented for an inflamed leukogram, which was likely due to stress, since
inflamed leukograms are often seen in small breed dogs such as Chihuahuas. The sample
population also contained 2 animals presenting for mild dehydration, 4 presenting for
anemia, and 6 presenting for internal and/or external parasites. Of all 18 dogs, 4 had
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blood cell counts that were within normal limits as determined by the clinical pathologist
and assigned a health grade of 0. Only two dogs (Dogs 09 and 20) were classified with
the highest health grade of 4. The remaining 12 dogs were either grade 1 or grade 2 (see
Appendix D)
Table 2

Classification of thirteen pregnant bitches as early, mid, or late gestation

Early Gestation (20-50
Days)

Mid-Gestation
(30-50 Days)

Late Gestation
(>50 Days)

Dog 07
Dog 08
Dog 09

Dog 10
Dog 11
Dog 12

Dog 13

Dog 14
Dog 16
Dog 17

Dog 15

Dog 19

Dog 21
Relaxin
Samples from 17 of the 18 animals were used in the relaxin radioimmunoassay
since specimen collection on Dog 21 was not complete when the assay was performed.
Due to time constraints, fecal relaxin was only calculated for two animals. The relaxin
RIA was performed three times on serum relaxin at quantities of 100 μl, 10 μl, and 2 μl
due to the high serum concentrations of relaxin found in the dog. The percent of specific
binding for serum concentrations was 18.62%, 17.25%, and 15.35% respectively, and the
percent of nonspecific binding was 8.62%, 13.14%, and 13.77% respectively. The relaxin
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RIA was performed twice on urine relaxin at quantities of 100 μl and 10 μl. The percent
of specific binding for urine concentrations was 11.80% and 10.43% respectively, and the
percent of nonspecific binding was 13.02% and 9.16% respectively. The two fecal
extracts were run once at 100 μl. The percent of specific binding for fecal extracts was
4.47%, and the percent of nonspecific binding was 16.66%. The average intra-assay
coefficient of variation was 4.4% for all relaxin RIAs performed, and the overall
interassay coefficient of variation was 19.5%.
Serum concentrations of relaxin ranged from 0.02−11 μg/ml in pregnant bitches
with a mean concentration of 3.5 ± 2.4 μg/ml. In contrast, relaxin was undetectable in the
serum of non-pregnant bitches and males. Urine concentrations of relaxin ranged from 0
to 24.1 ng/mg creatinine in non-pregnant bitches and from 0.78−480 ng/mg creatinine in
pregnant bitches, with mean concentrations of 10.8 ± 30.5 ng/mg creatinine and 108 ±
100 ng/mg creatinine respectively. Relaxin was also detected in the urine of the two male
dogs with a mean concentration of 7.2 ± 58.0 ng/mg creatinine. Urine concentrations of
relaxin were 3.6% of their respective serum concentrations. Concentrations of relaxin for
the two fecal samples were reported as 13.86 ng/ml for the pregnant bitch (Dog 09) and
20.94 ng/ml for the male (Dog 20).
Serum concentrations of relaxin correlated with urine concentrations for the total
sample population (r15 = 0.74, P < 0.001), for pregnant and non-pregnant bitches (r13 =
0.78, P < 0.001), and for pregnant bitches only (r10 = 0.82, P = 0.001). Among pregnant
bitches, both serum (r10 = 0.69, P = 0.01) and urine concentrations of relaxin (r11 = 0.66,
P = 0.01) increased with gestational age (see Appendix B).
Serum concentrations of relaxin were higher in pregnant bitches ( x = 3546, SD =
3735) than in non-pregnant bitches ( x = 0, SD = 0; t11 = 3.29, P = 0.007) since serum
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relaxin was undetectable in non-pregnant bitches. Urine concentrations of relaxin were
94% higher in pregnant bitches ( x = 165, SD = 45.9) than in non-pregnant bitches ( x =
10.8, SD=12.3; t13 = 2.09, P = 0.05; see Appendix C). The highest concentration of
urinary relaxin among the non-pregnant group, both males and females, was 24.1 ng/mg
creatinine (see Table 3). There were four pregnant bitches whose concentrations of
urinary relaxin also fell below this number: Dog 09, Dog 13, Dog 16, and Dog 11.
Dog 09 and Dog 13 were the only two bitches in early gestation within the sample
population, and Dog 16 represented the only pregnant bitch to be carrying a litter of one
fetus. Dog 11 was likely a true false negative. Therefore, a urine concentration of 25
ng/mg creatinine of relaxin was capable of indicating pregnancy over 30 days in 9 out of
10 pregnant bitches as long as they were carrying multiple fetuses. This equals to a 90%
accuracy rate in this study.
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Table 3

Serum, urine, and fecal concentrations of relaxin in eighteen domestic dogs
as sorted by gestational age (GA)

Animal Pregna Gende Litter
ID
nt
r
Size
Dog 03
N
F
–
Dog 04
N
F
–
Dog 05
N
F
–
Dog 06
N
M
–
Dog 20
N
M
–
Dog 09
Y
F
12
Dog 13
Y
F
8
Dog 07
Y
F
5
Dog 14
Y
F
7
Dog 17
Y
F
3
Dog 21
Y
F
3
Dog 08
Y
F
11
Dog 16
Y
F
1
Dog 12
Y
F
5
Dog 11
Y
F
10
Dog 19
Y
F
6
Dog 10
Y
F
6
Dog 15
Y
F
5

GA
(days)
–
–
–
–
–
26 ± 3
29 ± 3
34 ± 3
38 ± 3
38 ± 3
40 ± 3
43 ± 3
44 ± 3
45 ± 3
48 ± 3
52 ± 3
57 ± 3
58 ± 3

Serum
(ng/ml)
0.00
0.00
0.00
0.00
0.00
19.97
87.44
785.70
2954.59
1894.87
–
11649.03
1219.44
10291.32
2578.39
4277.39
3773.34
3023.37

Urine (ng/mg
creatinine)
0.00
8.18
24.14
11.78
2.65
0.78
2.38
27.48
53.38
16.14
27.98
163.25
22.73
59.17
1.11
452.41
480.28
97.31

Feces
(ng/ml)
–
–
–
–
20.94
13.86
–
–
–
–
–
–
–
–
–
–
–
–

Fibrinogen
Samples from all 18 animals were used to measure concentrations of fibrinogen.
The urine value on Dog 19 was excluded as an outlier since it was over 200 times higher
than the upper quartile for urine concentrations of fibrinogen. There is also no reported
fecal value for fibrinogen on Dog 19 because there was not an adequate amount of feces
remaining for the fibrinogen assay. The fibrinogen ELISA had to be performed twice on
serum and fecal samples due to initially poor results. Since the first set of serum and fecal
data reported as zero for all samples, this set of data was excluded from analysis. Since
assays were performed on different days, serum and fecal aliquots for fibrinogen
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underwent one freeze-thaw cycle during testing. A quantity of 2 μl was adequate for
performing the fibrinogen ELISA on serum, urine, and feces. The average intra-assay
coefficient of variance for the fibrinogen ELISA was 6.4%, and the overall interassay
coefficient of variance was 23.2%.
Serum concentrations of fibrinogen ranged from 4.3−15 μg/ml in non-pregnant
bitches and from 4.7−46 μg/ml in pregnant bitches, with mean concentrations of 8.8 ± 13
μg/ml and 18 ± 8.6 μg/ml respectively. Urine concentrations of fibrinogen ranged from
35−83 ng/mg creatinine in non-pregnant bitches and from 33−17000 ng/mg creatinine in
pregnant bitches, with mean concentrations of 67 ± 67 ng/mg creatinine and 3161.4 ±
3860.2 ng/mg creatinine respectively. Fecal concentrations of fibrinogen ranged from
5.5− 26 ng/ml in non-pregnant bitches and from 5.3−140 ng/ml in pregnant bitches, with
mean concentrations of 15 ± 26 ng/ml and 23 ± 24 ng/ml respectively. Mean
concentrations of fibrinogen for the two male dogs were 24 ± 84 μg/ml for serum, 1400
±16000 ng/mg creatinine for urine, and 380 ± 470 ng/ml for feces. Urine concentrations
of fibrinogen were 19.8% of their respective serum concentration, and fecal concentration
were 0.7% of their respective serum concentrations.
Serum concentrations of fibrinogen did not correlate with urine concentrations for
the total sample population (r15 = 0.36, P = 0.16), for pregnant and non-pregnant bitches
(r13 = 0.44, P = 0.10), or for pregnant bitches only (r10 = 0.25, P = 0.43). Serum
concentrations of fibrinogen also did not correlate with fecal concentrations for the total
sample population (r15 = 0.05, P = 0.84), for pregnant and non-pregnant bitches (r13 =
0.09, P = 0.75), or for pregnant bitches only (r10 = -0.02, P = 0.95). However, urine
concentrations of fibrinogen did correlate with fecal concentrations for the total sample
population (r15 = 0.51, P = 0.04), for pregnant and non-pregnant bitches (r13 = 0.53, P =
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0.04), and for pregnant bitches only (r10 = 0.69, P = 0.01). For pregnant bitches, serum
(r10 = -0.06, P = 0.85) and urine concentrations of fibrinogen (r11 = -0.46, P = 0.14) were
unrelated to gestational age. Fecal concentrations decreased with gestational age (r10 =
-0.60, P = 0.04; see Appendix B).
Serum concentrations of fibrinogen did not differ between pregnant bitches ( x =
17599, SD = 14266) and non-pregnant bitches ( x = 8818, SD = 5316; t10 =1.75, P =
0.11). Urine concentrations of fibrinogen did not differ between pregnant bitches ( x =
3161, SD = 6075) and non-pregnant bitches ( x = 66.53, SD = 26.90; t11 = 1.76, P =
0.11). Fecal concentrations of fibrinogen did not differ between pregnant bitches ( x =
23.18, SD = 37.80) and non-pregnant bitches ( x = 15.49, SD = 10.39; t13 = 0.62, P =
0.55; see Appendix C).
Urine concentrations of < 90 ng/mg creatinine were associated with all nonpregnant bitches, males, early gestation bitches, and late gestation bitches except for one
male (Dog 09) and one early gestation bitch (Dog 20). Since both Dogs 09 and 20 were
the only two animals to receive a grade 4 health status for elevations in multiple white
blood cells, their elevated urine concentrations could be attributed to inflammation or
infection. All mid-gestation bitches had urine concentrations of fibrinogen > 90 ng/mg
creatinine except for one (Dog 21; see Table 4).
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Table 4

Serum, urine, and fecal concentrations of fibrinogen in eighteen domestic
dogs as sorted by gestational age (GA)

Animal
Pregnant Gender
ID
Dog 03
Dog 04
Dog 05
Dog 06
Dog 20
Dog 09
Dog 13
Dog 07
Dog 14
Dog 17
Dog 21
Dog 08
Dog 16
Dog 12
Dog 11
Dog 19
Dog 10
Dog 15

N
N
N
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

F
F
F
M
M
F
F
F
F
F
F
F
F
F
F
F
F
F

Litter
Size

GA
(days)

–
–
–
–
–
12
8
5
7
3
3
11
1
5
10
6
6
5

–
–
–
–
–
26 ± 3
29 ± 3
34 ± 3
38 ± 3
38 ± 3
40 ± 3
43 ± 3
44 ± 3
45 ± 3
48 ± 3
52 ± 3
57 ± 3
58 ± 3

Serum
(ng/ml)
4341.04
14693.64
7419.83
12348.99
7075.18
9557.45
8875.16
6187.75
32741.58
10192.77
10481.12
37077.77
15300.93
33450.52
46096.66
7182.16
4665.34
6989.53

Urine
(ng/mg
creatinine)
35.49
83.06
81.03
85.47
2651.83
17114.24
54.27
3986.30
704.14
345.29
33.01
14703.32
562.36
112.69
206.92
–
34.22
79.49

Feces
(ng/ml)
14.76
26.24
5.49
415.76
341.18
140.69
6.31
23.53
14.76
8.49
12.62
18.29
29.06
5.72
5.84
–
7.57
5.27

Alpha-1 Acid Glycoprotein
Samples from all 18 animals were used to measure concentrations of AGP. The
serum value on Dog 16 was excluded as an outlier since it was over 5 times higher than
the upper quartile for serum concentrations of AGP. There is also no reported fecal value
for fibrinogen on Dog 19 because there was not an adequate amount of feces remaining
for the AGP assay. The AGP ELISA was performed twice on fecal samples, and the first
set of fecal concentrations were excluded due to a high intra-assay coefficient of
variation. Since assays were performed on different days, fecal aliquots for AGP
underwent one freeze-thaw cycle during testing. A quantity of 5 μl was adequate for
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performing the AGP ELISA on serum, urine, and feces. The average intra-assay
coefficient of variance for the AGP ELISA was 5.9%, and the overall interassay
coefficient of variance was 33.6%.
Serum concentrations of AGP ranged from 25.1−1790 μg/ml in non-pregnant
bitches and from 185−1710 μg/ml in pregnant bitches, with mean concentrations of 805 ±
2120 μg/ml and 949 ± 320 μg/ml respectively. Urine concentrations of AGP ranged from
0−6470 ng/mg creatinine in non-pregnant bitches and from 0−336000 ng/mg creatinine in
pregnant bitches, with mean concentrations of 3310 ± 8050 ng/mg creatinine and 47700 ±
61800 ng/mg creatinine respectively. Fecal concentrations of AGP ranged from 0−131
ng/ml in non-pregnant bitches and from 0−239 ng/ml in pregnant bitches, with mean
concentrations of 43.6 ± 188 ng/ml and 51.9 ± 53.0 ng/ml respectively. Mean
concentrations of AGP for the two male dogs were 1150 ± 922 μg/ml for serum and 2580
± 3270 ng/mg creatinine for urine. Alpha-1 acid glycoprotein was detectable in the feces
of only 7 out of the 17 animals sampled. Urine concentrations of AGP were 2.8% of their
respective serum concentrations.
Serum concentrations of AGP correlated with urine concentrations for the total
sample population (r15 = 0.57, P = 0.02), for pregnant and non-pregnant bitches (r13 =
0.65, P = 0.01), and for pregnant bitches only (r10 = 0.73, P = 0.01). Serum
concentrations of AGP did not correlate with fecal concentrations for either the total
sample population (r15 = -0.02, P = 0.10), for pregnant and non-pregnant bitches (r13 =
0.01, P = 0.98), or for pregnant bitches only (r10 = -0.36, P = 0.27). For pregnant bitches,
both serum (r10 = 0.65, P = 0.02) and urine concentrations of AGP (r11 = 0.50, P = 0.08)
increased with gestational age; whereas, fecal concentrations of AGP were unrelated to
gestational age (r10 = -0.35, P = 0.27; see Appendix B).
41

Serum concentrations of AGP did not differ between pregnant bitches ( x =
949194, SD = 504228) and non-pregnant bitches ( x = 804559, SD = 854557; t2 = 0.28, P
= 0.80). Urine concentrations of AGP did not differ between pregnant bitches ( x =
47695, SD = 102189) and non-pregnant bitches ( x = 3313, SD = 3238; t12 = 1.56, P =
0.14). Fecal concentrations of AGP did not differ between pregnant bitches ( x = 51.90,
SD = 84.99) and non-pregnant bitches ( x = 43.59, SD = 75.50; t4 = 0.17, P = 0.88; see
Appendix C).
Urine concentrations of AGP were undetectable in all but one pregnant bitch
under Day 40 of gestation. That exception was again Dog 09, which had a grade 4 health
status. All pregnant bitches over Day 40 and one pregnant bitch at Day 38 had urine
concentrations of AGP of 715 ng/mg creatinine or higher. Of the non-pregnant bitches,
only one had undetectable concentrations of AGP in urine; the other two had
concentrations > 3000 ng/mg creatinine (see Table 5).
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Table 5

Serum, urine, and fecal concentrations of alpha-1 acid glycoprotein in
eighteen domestic dogs as sorted by gestational age (GA)

Animal Pregnan
Litter
Gender
ID
t
Size
Dog 03
N
F
–
Dog 04
N
F
–
Dog 05
N
F
–
Dog 06
N
M
–
Dog 20
N
M
–
Dog 09
Y
F
12
Dog 13
Y
F
8
Dog 07
Y
F
5
Dog 14
Y
F
7
Dog 17
Y
F
3
Dog 21
Y
F
3
Dog 08
Y
F
11
Dog 16
Y
F
1
Dog 12
Y
F
5
Dog 11
Y
F
10
Dog 19
Y
F
6
Dog 10
Y
F
6
Dog 15
Y
F
5

GA
Urine (ng/mg
Feces
Serum (ng/ml)
(days)
creatinine)
(ng/ml)
–
1788778.11
3466.86
130.76
–
373700.41
6472.28
0.00
–
251198.58
0.00
0.00
–
1072651.27
5153.04
0.00
–
1217737.05
0.00
0.00
26 ± 3
656306.97
18388.96
129.34
29 ± 3
248792.48
0.00
0.00
34 ± 3
184794.69
0.00
239.35
38 ± 3
787744.78
0.00
0.00
38 ± 3
1280638.55
29846.69
11.05
40 ± 3
500490.92
739.84
0.00
43 ± 3
1148643.00
5189.16
187.11
44 ± 3
–
568.07
51.09
45 ± 3
1554468.96
8593.58
0.00
48 ± 3
1449405.90
19370.29
0.00
52 ± 3
1120545.90
200515.86
–
57 ± 3
751638.16
714.91
4.92
58 ± 3
1706857.35
336113.41
0.00
Ceruloplasmin

A trial set of serum, urine, and fecal extracts from four dogs (3 pregnant bitches, 1
male) was sent to the Memphis Zoo (Memphis, TN) for ceruloplasmin testing (see
Table 6). There was only low amount of ceruloplasmin present in the urine and feces, and
duplicate values may be indicative of baseline values in the assay. Negative
concentrations for the urine suggest that those samples needed to be rerun at different
dilutions, but unfortunately, there was not enough sample remaining to do so.
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Table 6

Serum, urine, and fecal concentrations of ceruloplasmin in four domestic
dogs

Animal ID Gender
Dog 06
Dog 10
Dog 13
Dog 21

M
F
F
F

Litter
Size
–
6
8
3

GA (days)
–
57 ± 3
29 ± 3
40 ± 3

Serum
Urine
(ng/ml) (ng/mg creatinine)
3.86
-0.7
4.29
-0.7
2.57
0.56
4.29
0
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Feces
(ng/ml)
0.43
0
0
0.43

CHAPTER V
DISCUSSION
Relaxin, fibrinogen, and alpha-1 acid glycoprotein were detected in the urine of
the domestic dog. Relaxin and fibrinogen were also detected in the feces of the domestic
dog although fecal fibrinogen was low compared to serum and urine concentrations. This
is the first reported instance in which relaxin, the pregnancy-specific hormone for
canines, was detected in the urine of the domestic dog and is also the first reported study
to evaluate the presence of relaxin in fecal samples. Although serum, urine, and fecal
concentrations of fibrinogen and AGP were not significant for detecting pregnancy in this
study, urinary relaxin appeared to be capable of detecting pregnancy at concentrations of
25 ng/mg creatinine or higher in bitches over 30 days past the LH surge as long as they
were carrying multiple fetuses.
Relaxin
Serum concentrations of relaxin can typically elevate to 8−10 μg/ml during
pregnancy in the domestic dog, generally reaching these higher concentrations around
Day 40 to 50 after the LH surge (Steinetz et al., 1996; Steinetz et al., 1987). This was true
among the pregnant bitches within our sample population, two of which reached serum
concentrations > 10 μg/ml. Both of these bitches were close to Day 45 of gestation.
Although serum and urine concentrations of relaxin correlated well, urine concentrations
were markedly lower than serum concentrations and did not reach the high concentrations
seen with serum relaxin in domestic bitches. This was somewhat unexpected as the study
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by De Haas van Dorsser et al. (2006) showed similar mean concentrations of relaxin for
serum and urine, differing by only 1−3 ng/ml, in pregnant felids. The difference could be
attributed to a difference in renal physiology and degradation and reabsorption rates
between the two species. Relaxin is believed to have profound effects upon the renal
system during pregnancy in humans and rats, increasing glomerular filtration rate and
renal plasma flow (Bogzil et al., 2005; Conrad and Novak, 2004; Smith et al., 2006). If
relaxin has similar functions in the domestic dog, it could be possible that the high
concentrations of relaxin in the circulating blood are being partially consumed and
metabolized by the renal system prior to excretion.
Because this study was limited to a one-time sample collection of each animal,
there was little means to investigate whether or not there was any lag time involved in the
excretion rates of urinary relaxin. While serum concentrations are representative of
concentrations of relaxin in the circulating blood at the time of blood collection, urine
concentrations would likely be representative of concentrations of relaxin in circulating
blood days prior to the time of urine collection. In the study on urinary relaxin in felids,
serum concentrations of relaxin became elevated around Day 21; whereas, urine
concentrations did not become elevated until a week later (De Haas van Dorsser et al.,
2006). This is likely why serum relaxin was capable of identifying pregnancy in the two
early gestation bitches in this study while urinary relaxin was not. If urinary relaxin is to
be used for pregnancy diagnosis in canines, it would be beneficial to develop an overall
profile of urinary relaxin during pregnancy in the domestic bitch in order to isolate the
exact day at which urinary relaxin becomes elevated. Based upon the results of this study,
urinary relaxin appears to become elevated between 30-35 days after the LH surge.
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Urinary Relaxin in the Non-Pregnant Bitch and Male Dog
It was interesting to note that in this study, while relaxin was undetectable in the
serum of non-pregnant bitches and males, it was present in the urine of both males and
two of the three non-pregnant bitches. This differs from the studies on felids and maned
wolves where urinary relaxin, like serum relaxin, was undetectable in non-pregnant
females and in males (De Haas van Dorsser et al., 2006; Steinetz et al., 2009). It could be
possible that something within the urine is causing interference with the relaxin
radioimmunoassay. If that is the case, an extraction process might be needed. However,
De Haas van Dorsser et al. (2006) found that an extraction process for relaxin on cat
urine resulted in 10-fold losses in concentration and, therefore, favored using unextracted
cat urine. The other possibility is that trace amount of relaxin are excreted in the urine of
non-pregnant bitches and males. In non-pregnant bitches, the source of these low
amounts of relaxin could be attributed to the ovary. While the placenta is the primary
source for relaxin production in the domestic dog, relaxin is also produced in smaller
amounts by the ovary (Klonisch et al., 1999; Steinetz et al., 1989). In the mare, the corpus
luteum is thought to be the source of relaxin production by the ovary since relaxin gene
expression and production in the ovary are greatest during the luteal phase, declining
after luteolysis (Ryan et al., 1997). Since both of the two non-pregnant bitches with traces
of relaxin immunoreactivity in their urine (Dog 04 and 06) had several corpus lutea
present on their ovaries, it is possible that this is also true for the domestic dog. In
contrast, the one non-pregnant bitch for which relaxin was undetectable in the urine
(Dog 03) showed very little ovarian activity histologically. Serum concentrations of
relaxin are known to be significantly lower in ovariectomized bitches as compared to
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unaltered bitches, and it has been suggested that ovarian relaxin contributes to total
circulating concentrations of relaxin (Steinetz et al., 1989).
Additionally, relaxin has been found in the testis and seminal fluid of many
species including chickens, pigs, humans, baboons, cattle, goats, guinea pigs, and rats
(Sherwood, 2004; Weiss, 1989). Relaxin produced in the male reproductive tract is
excreted primarily in the seminal fluid and is thought to function in sperm motility
(Sherwood, 2004). Relaxin in seminal fluid can reach concentrations as high as 40 ng/ml
in bulls (Kohsaka et al., 2003). Neither of the male dogs in this study exhibited
concentrations of urinary relaxin as high as this, both having urine concentrations below
12 ng/ml. Studies on perineal hernias in male dogs have shown that relaxin is expressed
in the prostate and paraprostatic tissues of the domestic dog (Niebauer et al., 2005).
Whether or not the relaxin in the urine of the two male dogs is actually urinary relaxin or
whether it is simply residual concentrations left by seminal fluid is uncertain considering
both male dogs were intact prior to sample collection. It is interesting to note that the
urine sample from Dog 06, which was collected in late February during the typical spring
breeding period for many domestic dogs, had a higher concentration of relaxin than the
urine sample from Dog 20, which was collected in mid-June. Seminal relaxin has been
demonstrated to exhibit monthly patterns in bonnethead sharks (Gelsleichter et al., 2003).
Therefore, it may be of interest to perform a more in-depth study of urinary relaxin in
male dogs to evaluate its origin and determine if male dogs exhibit seasonal reproductive
patterns for relaxin.
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Fecal Relaxin
Relaxin immunoreactivity was found in the fecal extracts of two domestic dogs,
one a pregnant bitch and the other a male dog. Based upon the results from these two
samples, it was originally determined that fecal relaxin would not be useful for pregnancy
diagnosis since the male dog had a higher fecal concentration of immunoreactive relaxin
than did the pregnant bitch, and due to time constraints, no further investigation was
made. However, upon further review of the data, the particular bitch (Dog 09) for which
fecal relaxin was measured was found to be one of the early gestation bitches that
presented as a false negative with urinary relaxin. Therefore, a lower concentration in
Dog 09 might not necessarily reflect on fecal relaxin in other pregnant bitches, as
originally thought, and it might be worthwhile to further examine the potential of fecal
relaxin for pregnancy testing. If it is indeed relaxin being measured in the feces, this
would be the first reported evidence of fecal relaxin to date.
The two fecal concentrations of immunoreactive relaxin were higher in
concentration than their respective urine concentrations and, therefore, may be more
comparable to serum concentrations. Since relaxin is a protein hormone and not a steroid
hormone, there is some concern in regards to degradation and reabsorption within the
gastrointestinal tract. The mechanism by which relaxin is degraded is not very well
understood, but studies have shown that relaxin can act as a substrate for and is rapidly
degraded by insulin-degrading enzyme. However, relaxin has a relatively low affinity for
binding with insulin-degrading enzyme, insulin being the more preferable substrate
(Bennett et al., 2009; Pilistine and Varandani, 1986). Therefore, it may be possible that
relaxin is excreted in the feces with minimal losses in concentration. Further study into
the degradation mechanism for relaxin is needed, however, to support this suggestion.
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Additionally, another issue that needs to be addressed in regards to fecal relaxin,
especially if it is to be used with wild populations, is the degradation of relaxin by fecal
bacteria. Chemical changes caused by bacteria or by improper storage procedures could
potentially skew concentrations due to cross-reactivity with other molecules. Such
problems have been well documented and addressed with steroid hormones, such as
estrogen and glucocorticoids, which can decompose hours after defecation (Khan et al.,
2002; Moestl et al., 1999). However, these issues have not yet been addressed with
protein hormones.
Acute-Phase Proteins
Since the study by Vannucchi et al. (2002) on serum AGP used a different method
of measuring AGP than this study, it was difficult to determine if our serum AGP
concentrations were comparable. However, serum concentrations of fibrinogen were
extremely low as compared to other studies in which fibrinogen was found to range as
high as 300−800 mg/dl in the serum of pregnant bitches (Root Kustritz, 2005; Ulutas et
al., 2009; Vannucchi et al., 2002). The highest serum concentration of fibrinogen within
the whole sample population for this study was 11.52 mg/dl. Why serum concentrations
of fibrinogen were so low in this study is uncertain. However, the serum aliquots for
fibrinogen did undergo a freeze-thaw cycle during the testing process. Acute-phase
proteins appear to be particularly sensitive to freeze-thaw cycles. For example,
concentrations of ceruloplasmin have been known to decrease by 33% by the second
thawing and by 50% by the fourth thawing (Willis et al., 2011). Furthermore, while urine
and fecal concentrations of fibrinogen did not correlate with serum concentrations, urine
and fecal concentrations did show a positive correlation with each other. This could be
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further indication that the serum concentrations of fibrinogen were negatively affected by
the extra freeze-thaw cycle during testing and might not necessarily be a reliable
representation.
Neither fibrinogen nor AGP were found to be statistically significant for
pregnancy in serum, urine, or feces. This could be due in part to the questionable health
status of the sample population. Since the sample population was a random assortment of
dogs from local animal shelters, there was no medical history available beyond the
veterinarian's one-time health assessment at the time of sample collection. Furthermore, it
was virtually impossible to differentiate elevations in fibrinogen and AGP that were
caused by pregnancy from those elevations caused by inflammation based solely on CBC
results. However, there were a few tentative observations that could be made about urine
concentrations of fibrinogen and AGP. First, urine concentrations of fibrinogen appeared
to be elevated in pregnant bitches between Days 30−50 as compared to lower
concentrations seen in non-pregnant bitches and bitches in early and late gestation. If a
lag time of a few days is assumed for urine concentrations, then this is fairly consistent
with the elevation of serum concentrations of fibrinogen reported as being between Day
25-50 by Concannon et al. (1995). Likewise, urine concentrations of AGP appeared to
become elevated beyond Day 40 as compared to mostly undetectable concentrations for
bitches earlier in gestation. This coincides fairly conveniently with the peak in serum
concentrations of AGP noted to occur around the 6th week of gestation (Vannucchi et al.,
2002). However, 2 of the 3 non-pregnant bitches had urine concentrations of AGP as high
or higher than the concentrations seen among pregnant bitches, and there was no way of
differentiating between the two groups. Furthermore, as stated earlier, there was also no
way to confirm whether or not these elevations in fibrinogen and AGP could be attributed
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solely to pregnancy status. Even so, the urine concentrations for both fibrinogen and AGP
were more explicable in relation to pregnancy than were their respective serum
concentrations. This could be due to a reduction of sporadic patterns of secretion caused
by pooling of the urine in the bladder (Monfort, 2003).
While this study does provide evidence for the presence of fibrinogen and AGP in
the urine of the domestic dog, a more controlled study in which the health of the sample
population can be reliably monitored and assessed is needed before their usefulness for
noninvasive pregnancy testing can be fully determined. If anything, the results on
fibrinogen and AGP are witness to the difficulty of using acute-phase proteins for
pregnancy diagnosis with animals of limited or unknown medical histories. Therefore,
even if a noninvasive pregnancy test could be validated for fibrinogen or AGP in the
domestic dog, it would not be applicable for use on canines within wild populations
where diseases and infections are likely even more problematic than with our sample
population of stray dogs. Any application for pregnancy diagnosis with acute-phase
proteins would be limited to zoo populations, where health can actually be monitored.
Acute-phase proteins like fibrinogen and AGP typically increase around 8 hours after an
inflammatory stimulus and then remain elevated between 24 and 48 hours (Gruys et al.,
2005). Therefore, in a zoo setting where urine samples can be routinely collected and
tested, it may be much easier to rule out the possibility of elevations due to infection.
Implications of the Study
While serum relaxin would still be the more preferable method of diagnosing
pregnancy in the domestic dog due to its 100% accuracy rate even in early gestation
bitches, the benefit of urinary relaxin is that it is noninvasive and eliminates stress caused
52

by blood collection. Therefore, urinary relaxin would be the more preferable method in
nondomestic canines, especially captive populations that are more susceptible to captivity
stress and its negative effects on reproduction. Additionally, the ability to measure relaxin
in urine may provide wildlife biologists the opportunity to study pregnancy rates and
other reproductive factors in wild populations of some nondomestic canines since it is
possible to collect frozen urine samples from snow for analysis. Most nondomestic
canines experience gestation around late winter to early spring, so it would be possible to
collect frozen urine samples for pregnancy diagnosis on species found in areas of long
periods of snow cover, such as with the wolf (Mech et al., 1987).
Furthermore, this is the first study to detect relaxin in feces of the domestic dog.
Although further study is needed to support the finding of fecal relaxin, the implications
of this for wildlife biologists studying reproduction in nondomestic canines would be
enormous considering that scat samples are far more easily obtained from free-ranging
populations than serum samples or even urine samples. With noninvasive genetic
sampling possible with feces, wildlife biologists could potentially measure relaxin and
determine the specific individual to which the scat belongs and the gender of that
individual (Waits and Paetkau, 2005). Furthermore, since progesterone can be measured
from fecal samples, it would also be possible to evaluate pregnancy rates,
pseudopregnancy rates, and anovulatory rates in wild populations, which could greatly
benefit the study of canine reproductive biology.
Conclusion
Due to the diverse nature of the sample population, this study was not able to
evaluate factors such as breed, maternal weight, or litter size and their relationship to
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concentrations of relaxin and acute-phase proteins. Breed, maternal weight, and litter size
are thought to influence serum concentrations of relaxin in the domestic bitch (Synbiotics
Corporation, 2012). Additionally, large differences in concentrations of relaxin have been
seen between breeds in the mare (Stewart et al., 1992). In contrast, no such studies have
been done to assess the effects of such factors on concentrations of acute-phase protein.
Therefore, it might be beneficial to characterize the relationship of breed, maternal
weight, and litter size with concentrations of relaxin and acute-phase proteins.
Suggestions for future research also include evaluating 1) lag times for urine and fecal
concentrations, 2) recovery rates within urine and fecal samples, 3) the source of urinary
and fecal relaxin in the male dog, 4) seasonality of urinary relaxin within the male dog,
5) hormonal profiles for pregnant bitches, 6) effects of freeze-thaw cycles on fibrinogen
and AGP, 7) storage methods for fecal samples, and 8) the effect of degradation by fecal
bacteria upon relaxin.
Although this study could not reliably confirm the ability of urinary fibrinogen or
urinary AGP to detect pregnancy in the domestic dog, these two acute-phase proteins
warrant further research with a more accessible sample population for which health
factors can be controlled and evaluated. Such a study may well unveil the potential of
acute-phase proteins in noninvasive pregnancy diagnosis for canines. Further research is
also needed to confirm the presence of relaxin within the feces of the domestic dog and
determine whether or not fecal relaxin is capable of indicating pregnancy in the domestic
dog. However, this study presents the first evidence for the use of urinary relaxin as a
method of noninvasive pregnancy diagnosis in the domestic dog, which may be used as a
basis for the development of similar noninvasive pregnancy tests in other nondomestic
canine.
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APPENDIX A
CANINE FETAL DEVELOPMENT
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Table 7
Day of
Gestation
Day 16−18
Day 23
Day 24
Day 25
Day 28
Day 30
Day 32
Day 33
Day 35
Day 36
Day 40
Day 42
Day 45
Day 49
Day 55

Fetal development chart for the domestic dog adapted from Pineda (2003)
and Pretzer (2008)
Length

Noticeable Physical Development

—
Implantation occurs.
0.5−1.0 cm First limb buds are visible.
0.5−1.4 cm Thoracic limb buds are present; eyes are first visible.
1.0−1.4 cm Mammary ridge is present.
First ossification is seen in mandible, maxilla, frontal bone,
1.2−1.7 cm
and clavicle.
Eyelids and external ears are forming; distinct forelimb
1.9 cm
digits are present.
2.3−2.7 cm Sexual differentiation occurs.
Ossification is developing in facial bones, ribs, and the
2.7 cm
mid-shaft of several long bones; the palatal shelves have
fused; and there are distinct digits on the hind paws.
Developing eyelids cause the eye to be almost closed; the
2.8−4.1 cm
pinna covers the opening of the ear; claws are developing.
—
Testicular differentiation occurs.
Eyes are closed, and the eyelids are fused; claws have
—
developed on all digits.
4.0−9.0 cm Fetus is fully developed.
Color markings appear on the body; hair begins to form;
—
scrotal swellings are large in males, and labia are present in
females.
9.0−10.0 cm Hair is present.
—

All deciduous teeth are calcified.
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APPENDIX B
SCATTER PLOTS FOR SERUM, URINE, AND FECAL CONCENTRATIONS OF
RELAXIN, FIBRINOGEN, AND AGP WITH GESTATIONAL AGE OF
THIRTEEN PREGNANT BITCHES
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Figure 1

Scatter plot between serum relaxin and day of gestation in thirteen pregnant
bitches (r = 0.69, P = 0.01)

Figure 2

Scatter plot between urinary relaxin and day of gestation in thirteen
pregnant bitches (r = 0.66, P = 0.01)
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Figure 3

Scatter plot between serum fibrinogen and day of gestation in thirteen
pregnant bitches (r = -0.06, P = 0.85)

Figure 4

Scatter plot between urinary fibrinogen and day of gestation in thirteen
pregnant bitches (r = -0.46, P = 0.14)
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Figure 5

Scatter plot between fecal fibrinogen and day of gestation in thirteen
pregnant bitches (r = -0.60, P = 0.04)

Figure 6

Scatter plot between serum AGP and day of gestation in thirteen pregnant
bitches (r = 0.65, P = 0.02)
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Figure 7

Scatter plot between urinary AGP and day of gestation in thirteen pregnant
bitches (r = 0.50, P = 0.08)

Figure 8

Scatter plot showing no correlation between fecal AGP and day of
gestation in thirteen pregnant bitches (r = -0.35, P = 0.27)
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APPENDIX C
T TEST RESULTS FOR SERUM, URINE, AND FECAL CONCENTRATIONS OF
RELAXIN, FIBRINOGEN, AND AGP FOR PREGNANCY STATUS IN
EIGHTEEN DOMESTIC DOGS
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Table 8

Independent t-test on serum concentrations of relaxin to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

Mean
3
12

Pooled
Satterthwaite

Std Dev

0
3546.2
-3546.2

Mean
0
3546.2
-3546.2
-3546.2

0
3735.1
3435.8

Std Err

Minimum Maximum
0
0
0
1078.2
19.97
11649
2217.8

95% CL Mean
Std Dev 95% CL Std Dev
0
0
0
−
−
1173.1 5919.4 3735.1 2645.9 6341.7
-8337.4
1245 3435.8 2490.8 5535.1
-5919.4 -1173.1

Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
11
2
Infty

13
11
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t Value
-1.6
-3.29

Pr > |t|
0.1338
0.0072

Pr > F
<.0001

Table 9

Independent t-test on urine concentrations of relaxin to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

3
13

Mean
Std Dev
Std Err Minimum Maximum
10.7719 12.2744
7.0866
0
24.135
108
165.4 45.8828
0.7848
480.3
-972588
153.2 98.1466

Mean
95% CL Mean
Std Dev 95% CL Std Dev
10.7719 -19.7193 41.2632 12.2744 6.3908 77.1413
108
8.0606
208
165.4
118.6
273.1
Pooled
-972588
-307.8
113.2
153.2
112.2
241.7
Satterthwaite -972588
-197.9 3.4186
Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

t Value
Pr > |t|
14
-0.99
0.3385
12.537
-2.09
0.0571

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
12
2
181.65
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Pr > F
0.011

Table 10

Independent t-test on serum concentrations of fibrinogen to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

3
13

Mean
Std Dev
Std Err Minimum Maximum
8818.2
5316.1
3069.2
4341
14693.6
17599.9 14266.1
3956.7
4665.3
46096.7
-8781.7 13359.8
8557.1

Mean
95% CL Mean
Std Dev 95% CL Std Dev
8818.2 -4387.7 22024 5316.1 2767.9 33410.1
17599.9
8979 26220.8 14266.1 10230 23549.5
Pooled
-8781.7 -27134.9 9571.4 13359.8
9781 21069.7
Satterthwaite -8781.7 19985.5 2422.1
Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

t Value
-1.03
-1.75

Pr > |t|
0.3222
0.1109

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
12
2
7.2

Pr > F
0.2565

14
9.7043
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Table 11

Independent t-test on urine concentrations of fibrinogen to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

3
12

Pooled
Satterthwaite

Mean
Std Dev
Std Err Minimum Maximum
66.526 26.8958 15.5283
35.4915
83.0578
3161.4
6075.6
1753.9
33.0097
17114.2
-3094.8
5588.8
3607.5

Mean
66.526
3161.4
-3094.8
-3094.8

95% CL Mean
Std Dev 95% CL Std Dev
-0.2869 133.3 26.8958 14.0035
169
-698.9 7021.6 6075.6 4303.9 10315.7
-10888.4 4698.8 5588.8 4051.6 9003.7
-6955.2 765.5

Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

t Value
Pr > |t|
13
-0.86
0.4065
11.002
-1.75
0.1054

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
11
2
51028.3
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Pr > F
<.0001

Table 12

Independent t-test on fecal concentrations of fibrinogen to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

3
12

Mean
Std Dev
Std Err Minimum Maximum
15.4947 10.3917
5.9997
5.492
26.236
23.1787 37.8028 10.9127
5.265
140.7
-7.684 35.0116 22.5999

Mean
95% CL Mean
Std Dev 95% CL Std Dev
15.4947 -10.3198 41.3091 10.3917 5.4105 65.3091
23.1787 -0.8401 47.1975 37.8028 26.7794 64.1846
Pooled
-7.684 -56.5081 41.1401 35.0116 25.3818 56.4052
Satterthwaite
-7.684 -34.7169 19.3489
Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

t Value
Pr > |t|
13
-0.34
0.7393
12.416
-0.62
0.5484

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
11
2
13.23
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Pr > F
0.1446

Table 13

Independent t-test on serum concentrations of AGP to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

3
12

Mean
Std Dev
Std Err Minimum Maximum
804559
854557
493379
251199 1788778
949194
504228
145558
184795 1706857
-144635
572258
369391

Mean
95% CL Mean
Std Dev
804559 -1318277 2927395 854557
949194 628823 1269565 504228
Pooled
-144635 -942656 653386 572258
Satterthwaite -144635 -2063852 1774583
DF

95% CL Std Dev
444932 5370662
357192 856117
414861 921932

Method
Pooled
Satterthwaite

Variances
Equal
Unequal

t Value
-0.39
-0.28

Pr > |t|
0.7017
0.8014

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
2
11
2.87

Pr > F
0.1983

13
2.3601
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Table 14

Independent t-test on urine concentrations of AGP to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

Mean
Std Dev
Std Err Minimum Maximum
3
3313
3238.9
1870
0
6472.3
13 47695.4
102189 28342.2
0
336113
-44382.4 94616.9 60603.3

Mean
95% CL Mean
Std Dev 95% CL Std Dev
3313 -4732.8 11358.9 3238.9 1686.4 20355.5
47695.4 -14057 109448 102189 73278.6 168688
Pooled
-44382.4 -174364 85598.8 94616.9 69271.6 149220
Satterthwaite -44382.4 -10621 17445.8
Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

t Value
Pr > |t|
14
-0.73
0.476
12.103
-1.56
0.1439

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
12
2
995.45
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Pr > F
0.002

Table 15

Independent t-test on fecal concentrations of AGP to evaluate mean
differences in concentrations between pregnant and non-pregnant bitches

Pregnant
N
Y
Diff (1-2)

N

Pregnant
N
Y
Diff (1-2)
Diff (1-2)

Method

3
12

Mean
Std Dev
Std Err Minimum Maximum
43.5873 75.4955 43.5873
0
130.8
51.9043 84.9883
24.534
0
239.4
-8.3169 83.5981 53.9623

Mean
43.5873
51.9043
Pooled
-8.3169
Satterthwaite -8.3169

95% CL Mean
-144 231.1
-2.0947 105.9
-124.9 108.3
-157.3 140.7

Std Dev 95% CL Std Dev
75.4955
39.3073 474.5
84.9883
60.2053 144.5
83.5981
60.6047 134.7

Method
Pooled
Satterthwaite

Variances
Equal
Unequal

DF

t Value
Pr > |t|
13
-0.15
0.8799
3.4059
-0.17
0.8773

Method
Folded F

Equality of Variances
Num DF
Den DF
F Value
11
2
1.27
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Pr > F
1

APPENDIX D
HEALTH ASSESSMENT AND COMPLETE BLOOD COUNTS FOR EIGHTEEN
DOMESTIC DOGS
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Dog 03
Dog 04
Dog 05
Dog 06
Dog 07
Dog 08
Dog 09
Dog 10
Dog 11
Dog 12
Dog 13
Dog 14
Dog 15
Dog 16
Dog 17
Dog 19
Dog 20
Dog 21

WNL

External
Parasites

Heartworms

Anemia

Elevated
Lymphocytes
Elevated
Neutrophils
Elevated
Monocytes
Elevated
Plasma Proteins
Reactive
Lymphocytes

Animal
ID

Health assessment of eighteen domestic dogs from northern Mississippi
based upon physical observations and results from complete blood counts
Elevated
Eosinophils

Table 16

X
X
X
X

X
X
X

X
X

X

X
X

X

X
X
X

X
X
X
X

X
X

X
X
X

X

X
X
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X
X

Health
Grade

1
1
0
2
0
1
4
2
2
2
1
1
2
0
1
0
4
2
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81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

